Trial Profile
Efficacy and Safety of Alendronate in Chinese Children or Adolescents With Osteogenesis Imperfecta: an Age Stratified Prospective Study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Alendronic acid (Primary)
- Indications Osteogenesis imperfecta
- Focus Therapeutic Use
- 06 Dec 2014 New trial record